Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice

Journal of Virology

Volumn 68, Issue 7, 1994, Pages 4358-4368

  Arbeit, Jeffrey M ^a   Münger, Karl ^b   Howley, Peter M ^b   Hanahan, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; MOUSE; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0028233614     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.7.4358-4368.1994     Document Type: Article

References (54)

1. Apple, R. J., H. A. Erlich, W. Klitz, M. M. Manos, T. M. Becker, and C. M. Wheeler. HLA DR-DQ disease associations in hispanic cervical carcinoma. Nat. Genet., in press.
2. Arbeit, J. M. 1993. Unpublished data.
3. Arbeit, J. M., K. Münger, P. M. Howley, and D. Hanahan. 1993. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORF's. Am. J. Pathol. 142:1187-1197.
4. Bailleul, B., M. A. Surani, S. White, S. C. Barton, K. Brown, M. Blessing, J. Jorcano, and A. Balmain. 1990. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 62:697-708.
5. Baker, C. C., W. C. Phelps, V. Lindgren, M. J. Braun, M. A. Gonda, and P. M. Howley. 1987. Structural and translational analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
6. Chellappan, S., V. B. Kraus, B. Kroger, K. Münger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553.
7. Cheng, J., K. Turksen, Q. C. Yu, H. Schreiber, M. Teng, and E. Fuchs. 1992. Cachexia and graft-vs.-host disease-type skin changes in keratin promoter driven TNF-a transgenic mice. Genes Dev. 6:1444-1456.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of isolation of RNA by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Cintorino, M., S. Syrjanen, P. Leoncini, E. Bellizi De Marco, R. Petracca, V. Pallini, P. Tosi, R. Mantyjarvi, and K. Syrjanen. 1988. Altered expression of filaggrin in human papillomavirus lesions of the uterine cervix. Arch. Gynecol. Obstet. 241:235-248.
10. Cotsarelis, G., T. Sun, and R. M. Lavker. 1990. Label-retaining cells reside in the bulge area of the pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61:1329-1337.
11. Crum, C. P., H. Ikenberg, R. M. Richard, and L. Gissmann. 1984. Human papillomavirus type 16 and early cervical neoplasia. N. Engl. J. Med. 310:880-883.
12. Crum, C. P., and G. Nuovo. 1991. Genital papillomaviruses and related neoplasms, p. 16-19. Raven Press, New York.
13. Cullen, A. P., R. Reid, M. Campion, and A. T. Lorincz. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and in invasive cervical neoplasm. J. Virol. 65:606-612.
14. Del Vecchio, A. M., H. Romanczuk, P. M. Howley, and C. C. Baker. 1992. Transient replication of human papillomavirus DNAs. J. Virol. 66:5949-5958.
15. Derynck, R., D. V. Goeddel, A. Ullrich, J. U. Gutterman, R. D. Williams, T. S. Bringman, and W. H. Berger. 1987. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47:707-712.
16. Dietrich, W., H. Katz, S. E. Lincoln, H. S. Shin, J. Friedman, N. C. Dracopoli, and E. S. Lander. 1992. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423-447.
17. Dyson, N., P. Guida, K. Münger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:6893-6902.
18. Dyson, N., P. M. Howley, K. Münger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
19. Eckert, R. L. 1989. Structure, function, and differentiation of the keratinocyte. Physiol. Rev. 69:1316-1346.
20. Fischer, S. M., J. F. O'Connell, C. J. Conti, K. C. Tacker, J. W. Fries, K. E. Patrick, and L. M. Adams. 1987. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis 8:421-424.
21. Gal, A. A., S. H. Saul, and M. H. Stoler. In situ hybridization analysis of human papillomavirus in anal squamous cell carcinoma. Mod. Pathol. 9:439-443.
22. Ha induces autonomous papillomas in transgenic epidermis hut not malignant conversion. Cancer Res. 53:5071-5075.
23. Greenhalgh, D. A., J. A. Rothangel, M. I. Quintanella, C. C. Orengo, T. A. Gagne, D. S. Bundman, M. A. Longley, and D. R. Roop. 1993. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog. 7:99-110.
24. Greenhalgh, D. A., J. A. Rothangel, X. J. Wang, M. I. Quintanella, C. C. Orengo, T. A. Gagne, D. S. Bundman, M. A. Longley, C. Fisher, and D. R. Roop. 1993. Hyperplasia, hyperkeratosis, and benign tumor formation in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia. Oncogene 8:2145-2157.
25. Greenhalgh, D. A., D. J. Welty, A. Player, and S. H. Yuspa. 1990. Two oncogenes, v-fos and v-ras cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 87:643-647.
26. Griep, A. E., R. Herber, S. Jeon, J. K. Lohse, R. R. Dubielzig, and P. F. Lambert. 1993. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 67:1373-1384.
27. Guo, L., Q. C. Yu, and E. Fuchs. 1993. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 12:973-986.
28. Han, R., F. Breibrud, P. N. Marche, and G. Orth. 1992. Linkage of regression and malignant conversion of rabbit papillomas to MHC class II genes. Nature (London) 356:66-68.
29. Hennings, H., A. B. Glick, D. T. Lowry, L. S. Krsmanovic, L. M. Sly, and S. H. Yuspa. FVB/n mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis, in press.
30. Hogan, B., F. Constantini, and E. Lacy. 1986. Manipulating the mouse embryo, p. 153-173. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
31. Howley, P. M. 1989. Papillomaviruses and their replication, p. 1625-1650. In B. N. Fields, D. M. Knipe, P. M. Chanock, M. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Virology, 2nd ed. Raven Press, New York.
32. Kondoh, G., Y. Murata, K. Aozasa, M. Yutsudo, and A. Hakura. 1991. Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice. J. Virol. 65:3335-3339.
33. Kopan, R., and E. Fuchs. 1989. A new look into an old problem: keratins as tools to investigate determination, morphogenesis, and differentiation in skin. Genes Dev. 3:1-15.
34. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonene, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327:1272-1278.
35. Lambert, P. F., H. Pan, H. C. Pilot, A. Liem, M. Jackson, and A. E. Griep. 1993. Epidermal cancer associated with expression of human papillomavirus type E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA 90:5583-5587.
36. Leder, A., A. Kuo, R. D. Cardiff, E. Sinn, and P. Leder. 1990. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effect of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87:9178-9182.
37. Merrick, D. T., R. A. Blanton, A. M. Gown, and J. K. McDougall. 1992. Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am. J. Pathol. 140:167-177.
38. Münger, K., M. Scheffner, J. M. Huibregste, and P. M. Howley. 1992. Interactions of HPV type 16 oncoproteins with tumour suppressor gene products. Cancer Surv. 12:197-217.
39. Münger, K., and H. Romanczuk. 1991. Unpublished data.
40. Rader, J. S., T. R. Golub, J. B. Hudson, D. Patel, M. A. Bedell, and L. A. Laimins. 1990. In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. Oncogene 5:571-576.
41. Scheffner, M. K., B. A. Werness, J. M. Huibregste, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
42. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (London) 314:111-114.
43. Shirasawa, H., Y. Tomita, K. Kubota, T. Kasai, S. Sekiya, H. Takamizawa, and B. Simizu. 1988. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J. Virol. 62:1022-1027.
44. Slaga, T. J., and S. M. Fischer. 1983. Strain differences and solvent effects in mouse skin carcinogenesis experiments using carcinogens, tumor initiators and promoters. Prog. Exp. Tumor Res. 26:85-109.
45. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680-4684.
46. Smotkin, D., H. Prokoph, and F. O. Wettstein. 1989. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63:1441-1447.
47. Stoler, A., R. Kopan, M. Duvic, and E. Fuchs. 1988. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J. Cell Biol. 107:427-446.
48. Turksen, K., T. Kupper, L. Degenstein, I. Williams, and E. Fuchs. 1992. Interleukin-6: insights to its function in skin by overexpression in transgenic mice. Proc. Natl. Acad. Sci. USA 89:5068-5072.
49. Vassar, R., P. A. Coulombe, L. Degenstein, K. Albers, and E. Fuchs. 1991. Mutant keratin expression in transgenic mice causes marked abnormalities resembling human genetic skin disease. Cell 64:365-380.
50. Vassar, R., and E. Fuchs. 1991. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev. 5:714-727.
51. Vassar, R., E. Hutton, and E. Fuchs. 1992. Transgenic overexpression of transforming growth factor a bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol. Cell. Biol. 12:4643-4653.
52. Vassar, R., M. Rosenberg, S. Ross, A. Tyner, and E. Fuchs. 1989. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 86:1563-1567.
53. Woodworth, C. D., S. Waggoner, W. Barnes, M. H. Stoler, and J. A. DiPaolo. 1990. Human cervical and foreskin epithelial cell immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res. 50:3709-3715.
54. zur Hausen, H. 1987. The role of papillomaviruses in human cancer. Cancer 59:1692-1696.